Literature DB >> 25572677

Expression of fucosyltransferase 8 is associated with an unfavorable clinical outcome in non-small cell lung cancers.

Rio Honma1, Ichiro Kinoshita, Eiji Miyoshi, Utano Tomaru, Yoshihiro Matsuno, Yasushi Shimizu, Satoshi Takeuchi, Yuka Kobayashi, Kichizo Kaga, Naoyuki Taniguchi, Hirotoshi Dosaka-Akita.   

Abstract

UNLABELLED: Objecitive: Fucosyltransferase 8 (FUT8), the only enzyme responsible for the core α1,6-fucosylation of asparagine-linked oligosaccharides of glycoproteins, is a vital enzyme in cancer development and progression. We examined FUT8 expression in non-small cell lung cancers (NSCLCs) to analyze its clinical significance. We also examined the expression of guanosine diphosphate-mannose-4,6-dehydratase (GMD), which is imperative for the synthesis of fucosylated oligosaccharides.
METHODS: Using immunohistochemistry, we evaluated the expression of FUT8 and GMD in relation to patient survival and prognosis in potentially curatively resected NSCLCs.
RESULTS: High expression of FUT8 was found in 67 of 129 NSCLCs (51.9%) and was significantly found in non-squamous cell carcinomas (p = 0.008). High expression of FUT8 was associated with poor survival (p = 0.03) and was also a significant and independent unfavorable prognostic factor in patients with potentially curatively resected NSCLCs (p = 0.047). High expression of GMD was significantly associated with high FUT8 expression (p = 0.04).
CONCLUSIONS: High expression of FUT8 is associated with an unfavorable clinical outcome in patients with potentially curatively resected NSCLCs, suggesting that FUT8 can be a prognostic factor. The analysis of FUT8 expression and its core fucosylated products may provide new insights for the therapeutic targets of NSCLCs. 2015 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25572677     DOI: 10.1159/000369495

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  27 in total

Review 1.  Glycosylation in cancer: its application as a biomarker and recent advances of analytical techniques.

Authors:  Yoshimi Haga; Koji Ueda
Journal:  Glycoconj J       Date:  2022-02-14       Impact factor: 2.916

2.  FUT4 is involved in PD-1-related immunosuppression and leads to worse survival in patients with operable lung adenocarcinoma.

Authors:  Chang Liu; Zhi Li; Shuo Wang; Yibo Fan; Simeng Zhang; Xianghong Yang; Kezuo Hou; Jianhua Tong; Xuejun Hu; Xiaonan Shi; Xiaoxun Wang; Yunpeng Liu; Xiaofang Che; Xiujuan Qu
Journal:  J Cancer Res Clin Oncol       Date:  2018-10-24       Impact factor: 4.553

3.  α1,6-Fucosyltransferase (FUT8) regulates the cancer-promoting capacity of cancer-associated fibroblasts (CAFs) by modifying EGFR core fucosylation (CF) in non-small cell lung cancer (NSCLC).

Authors:  Fengzhou Li; Shilei Zhao; Yanwei Cui; Tao Guo; Jiaqi Qiang; Qiang Xie; Wendan Yu; Wei Guo; Wuguo Deng; Chundong Gu; Taihua Wu
Journal:  Am J Cancer Res       Date:  2020-03-01       Impact factor: 6.166

4.  Fucosylation genes as circulating biomarkers for lung cancer.

Authors:  Qixin Leng; Jen-Hui Tsou; Min Zhan; Feng Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2018-08-12       Impact factor: 4.553

5.  Integrated glycomic analysis of ovarian cancer side population cells.

Authors:  Ran Zhao; Xiaoxia Liu; Congjian Xu; Shifang Ren; Yisheng Wang; Xiaoxiang Jie; Ruihuan Qin; Wenjun Qin; Mengyu Zhang; Haiyan Tai; Caiting Yang; Lili Li; Peike Peng; Miaomiao Shao; Xingwang Zhang; Hao Wu; Yuanyuan Ruan; Jianxin Gu
Journal:  Clin Proteomics       Date:  2016-11-10       Impact factor: 3.988

Review 6.  [Role of Fucosylation in Cancer].

Authors:  Kun Zhang; Hong Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-11-20

7.  Fucosyltransferase 4 shapes oncogenic glycoproteome to drive metastasis of lung adenocarcinoma.

Authors:  Hsuan-Hsuan Lu; Shu-Yung Lin; Rueyhung Roc Weng; Yi-Hsiu Juan; Yen-Wei Chen; Hsin-Han Hou; Zheng-Ci Hung; Giovanni Audrey Oswita; Yi-Jhen Huang; Shih-Yun Guu; Kay-Hooi Khoo; Jin-Yuan Shih; Chong-Jen Yu; Hsing-Chen Tsai
Journal:  EBioMedicine       Date:  2020-07-03       Impact factor: 8.143

Review 8.  Altered glycosylation in cancer: A promising target for biomarkers and therapeutics.

Authors:  Divya Thomas; Ashok Kumar Rathinavel; Prakash Radhakrishnan
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-11-04       Impact factor: 10.680

Review 9.  Enzymes for N-Glycan Branching and Their Genetic and Nongenetic Regulation in Cancer.

Authors:  Yasuhiko Kizuka; Naoyuki Taniguchi
Journal:  Biomolecules       Date:  2016-04-28

10.  Glycan array analysis of Pholiota squarrosa lectin and other fucose-oriented lectins.

Authors:  López-Cortés Rubén; Muinelo-Romay Laura; Fernández-Briera Almudena; Gil Martín Emilio
Journal:  Glycobiology       Date:  2021-05-03       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.